Table 2 Genotype distributions of SNPs, selected by univariate analysis of PFS, OS and toxicity

From: Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array

SNP

Wild type, N (%)

Heterozygotes, N (%)

Homozygote mutants, N (%)

Total, N

ATM rs1801516

63 (69.2)

24 (26.4)

4 (4.4)

91

ERCC5 rs1047768

28 (30.8)

46 (50.5)

17 (18.7)

91

GADD45A rs532446

49 (55.1)

31 (34.8)

9 (10.1)

89

LIG4 rs1805388

62 (68.1)

27 (29.7)

2 (2.2)

91

BARD1 rs2070093

62 (68.1)

25 (27.5)

4 (4.4)

91

ERCC2 rs238406

27 (30.0)

46 (51.1)

17 (18.9)

90